Paris, France and Eastleigh, UK – 30 January 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the High Court has notified Novacyt
Paris, France and Eastleigh, UK – 30 January 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the High Court has notified Novacyt
Approval of genesig® COVID-19 3G PCR test in the UK under CTDA legislation
A multiplex PCR test for the detection of winter viruses including SARS-CoV-2, influenza A and B, and RSV
The assay has been developed by Novacyt to support research efforts following a recent increase in cases of acute hepatitis in children
Approval of exsig™ COVID-19 Direct test in the UK under CTDA legislation
Trading update and progress against strategy for H1 2022
Paris, France and Camberley, UK – 28 June 2022 – Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), an international specialist in clinical diagnostics, announces the launch of its research-use-only